Intranasal Technology, Inc
Company Information
Saddle Brook, NJ
United States
Phone: 1 201 843 3308
Fax: 1 201 843 5255
Overview
ITI's mission is to develop novel proprietary nasal spray drug therapies that improve safety, convenience and efficacy for patients, their caregivers and health professionals; to offer employees rewarding opportunities; and to provide business partners and investors with superior returns.
Corporate Structure
CHIEF EXECUTIVE OFFICER
TOP EXECUTIVES
Paul Ashton Board of Directors
G. Steven Burrill Board of Directors
Michael J Ross Board of Directors
Bruce A. Peacock Board of Directors
Jordan Cohen Chairman of the Scientific Advisory Board
Robert Weisskoff Board of Directors
Susan R Mason Vice President of Clinical Operations
Sveinbjorn Gizurarson Board of Directors
Michael Lusty Vice President of Pharmaceutical Development
Daniel P Wermeling Board of Directors
Timothy I Mitchell Vice President Quality and Regulatory Affairs
Jeffery D Edelson Executive Vice President and Chief Medical Officer
Richard A Fisher Senior Vice President and Chief Scientific Officer
Franz F Hefti Senior Vice President and Chief Development Officer
Gregory G Plucinski Vice President of Manufacturing Operations
Edwin Cohen Founder
Sam R Sharar Board of Directors
Jacqueline A French Board of Directors
Kathleen Boziwick Vice President of Commercial Development
Jim Tullis Board of Directors
